Singapore Chapter of Rheumatologists consensus statement on the eligibility for government subsidy of biologic disease modifying anti-rheumatic agents for the treatment of psoriatic arthritis
10.1111/1756-185X.12685
Saved in:
Main Authors: | Lahiri, M, Teng, GG, Cheung, PP, Suresh, E, Chia, FL, Lui, NL, Koh, DR, Koh, WH, Leong, KP, Lim, AYN, Ng, SC, Thumboo, J, Lau, TC, Leong, KH |
---|---|
Other Authors: | DEAN'S OFFICE (MEDICINE) |
Format: | Article |
Published: |
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/207378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Clinical Outcomes of Early Intensive Treatment of Rheumatoid Arthritis
by: Prapan Booranaburidej, et al.
Published: (2022) -
A vaccination update for rheumatologists-SARS-CoV-2, influenza and herpes zoster
by: Wong, Peter KK, et al.
Published: (2021) -
The reliability, validity and sensitivity to change of the Chinese version of SF-36 in oriental patients with rheumatoid arthritis
by: Koh, E.T., et al.
Published: (2014) -
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
by: Santosa, Amelia, et al.
Published: (2021) -
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents
by: Lin, H.-S., et al.
Published: (2014)